Delphia Therapeutics Funding: $67M Raised, Series A (2024)
Delphia Therapeutics is a Biotech company. It has raised $67M in total funding. Latest round: Series A. Backed by GV, Nextech Invest, Polaris Innovation Fund.
Delphia Therapeutics funding overview
Delphia Therapeutics is a Biotech company. Delphia Therapeutics has raised $67M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in July 2024. The round record for Delphia Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include GV, Nextech Invest, Polaris Innovation Fund, Alexandria Venture Investments. 4 distinct backers are named across the disclosed rounds.
Frequently asked about Delphia Therapeutics funding
How much has Delphia Therapeutics raised?
Delphia Therapeutics has raised $67M in total disclosed funding across the rounds on record.
Who has invested in Delphia Therapeutics?
GV, Nextech Invest, Polaris Innovation Fund, Alexandria Venture Investments are named among the investors backing Delphia Therapeutics.
What was the latest Delphia Therapeutics funding round?
The most recent disclosed round is a Series A, announced in July 2024.
Where is Delphia Therapeutics based?
No headquarters location is disclosed for Delphia Therapeutics.
What sector does Delphia Therapeutics operate in?
Delphia Therapeutics is tracked under Biotech, with $67M in disclosed funding.
When did Delphia Therapeutics last raise?
The last disclosed Delphia Therapeutics round closed in July 2024 at Series A.
Every Delphia Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies at a similar stage.
